For Media
Connect With an Expert
BrightFocus Foundation’s in-house team of scientists are available for media interviews about Alzheimer’s disease, macular degeneration, and glaucoma. To arrange an interview, please contact Julia Roth at jroth@brightfocus.org.
Diane Bovenkamp, PhD, Vice President, Scientific Affairs
Diane Bovenkamp, PhD, Vice President of Scientific Affairs, is the chief scientist at BrightFocus Foundation, overseeing global operations of the organization’s research programs. She serves as the scientific liaison in local, national, and international forums, and identifies and develops new research initiatives, partnerships, and funding policies consistent with the mission of BrightFocus.
Dr. Bovenkamp obtained her PhD in biochemistry from Queen’s University in Kingston, Ontario, Canada, discovering and studying Eph receptors in angiogenesis and neural development in zebrafish and mice. She completed a postdoctoral fellowship in the Vascular Biology Program at Boston Children’s Hospital/Harvard Medical School, isolating and characterizing zebrafish neuropilins. Dr. Bovenkamp conducted further research at the Johns Hopkins University Bayview Proteomics Center in the Division of Cardiology at Johns Hopkins School of Medicine, using proteomic techniques for biomarker detection in human serum.
Sharyn Rossi, PhD, Senior Director of Neuroscience Programs
Dr. Sharyn Rossi received her PhD in anatomy and neurobiology from the University of California, Irvine, where she studied stem cell replacement therapies for the treatment of spinal cord injury. She continued her post-doctoral work at A.I. duPont Hospital for Children studying spinal muscular atrophy, and Johns Hopkins University, using optogenetics to investigate how transplanted stem cells integrate into brain circuitry after traumatic brain injury. Prior to joining BrightFocus, Dr. Rossi was a senior research scientist at the National Institute on Aging, using neuroimaging, light-sheet microscopy, and novel interventions to investigate changes in the brain during normal cognitive aging.
Latest Research News from BrightFocus-Funded Scientists
Beyond the Mouse Model: Studying Brain Tissue in a Dish
Dr. Dominik Paquet’s lab is growing human brain tissue in the lab to uncover what mouse models can’t show.
BrightFocus Journal Rises to Top 5 Neuroscience Journals Worldwide
With a 2025 impact factor of 19.6 and a No. 5 ranking among 330 neuroscience journals worldwide, Molecular Neurodegeneration continues to expand its influence on research into Alzheimer’s disease, macular degeneration, glaucoma, and related neurodegenerative disorders.
Breaking News Dispatch: Diversifying the Alzheimer’s Disease Treatment Portfolio
Read the latest research news and findings from the latest international Alzheimer’s conference.
Leqembi At-Home Injectable Now FDA Approved for Starting Alzheimer’s Treatment
The FDA has extended approval for the at-home formulation of Leqembi to include starter, in addition to maintenance, doses, making treatment more accessible.
BrightFocus Foundation, Alzheimer’s LA Fund New AI-Driven Alzheimer’s Research
Early-stage pilot grants aim to accelerate innovation and collaboration in Southern California.
BrightFocus Foundation Launches “Let’s Talk Alzheimer’s” Podcast Featuring Top Experts in Alzheimer’s Research
New podcast features world-class scientists and doctors discussing late-breaking Alzheimer’s and dementia research in plain language for families and caregivers.
Lessons from Zebrafish: Restoring “Ground Zero” in Macular Degeneration
BrightFocus Macular Degeneration Research grant recipient Lyndsay Leach, PhD, is investigating what makes another species capable of regrowing the part of the eye where age-related macular degeneration starts.
BrightFocus Foundation Announces President and CEO Planned Retirement and Launches National Search
BrightFocus Foundation today announced that Stacy Pagos Haller has shared her intention to retire as president and chief executive officer following the successful completion of a national search and the appointment of a successor, after 16 years of leadership.
Understanding the Causes of Steroid-Induced Glaucoma
A commonly used medication is linked to increased risk of glaucoma. A BrightFocus National Glaucoma Research-funded scientist is trying to understand why.
Beyond the Mouse Model: Studying Brain Tissue in a Dish
Dr. Dominik Paquet’s lab is growing human brain tissue in the lab to uncover what mouse models can’t show.
BrightFocus Journal Rises to Top 5 Neuroscience Journals Worldwide
With a 2025 impact factor of 19.6 and a No. 5 ranking among 330 neuroscience journals worldwide, Molecular Neurodegeneration continues to expand its influence on research into Alzheimer’s disease, macular degeneration, glaucoma, and related neurodegenerative disorders.
Breaking News Dispatch: Diversifying the Alzheimer’s Disease Treatment Portfolio
Read the latest research news and findings from the latest international Alzheimer’s conference.
Leqembi At-Home Injectable Now FDA Approved for Starting Alzheimer’s Treatment
The FDA has extended approval for the at-home formulation of Leqembi to include starter, in addition to maintenance, doses, making treatment more accessible.
BrightFocus Foundation, Alzheimer’s LA Fund New AI-Driven Alzheimer’s Research
Early-stage pilot grants aim to accelerate innovation and collaboration in Southern California.
BrightFocus Foundation Launches “Let’s Talk Alzheimer’s” Podcast Featuring Top Experts in Alzheimer’s Research
New podcast features world-class scientists and doctors discussing late-breaking Alzheimer’s and dementia research in plain language for families and caregivers.
Lessons from Zebrafish: Restoring “Ground Zero” in Macular Degeneration
BrightFocus Macular Degeneration Research grant recipient Lyndsay Leach, PhD, is investigating what makes another species capable of regrowing the part of the eye where age-related macular degeneration starts.
BrightFocus Foundation Announces President and CEO Planned Retirement and Launches National Search
BrightFocus Foundation today announced that Stacy Pagos Haller has shared her intention to retire as president and chief executive officer following the successful completion of a national search and the appointment of a successor, after 16 years of leadership.
Understanding the Causes of Steroid-Induced Glaucoma
A commonly used medication is linked to increased risk of glaucoma. A BrightFocus National Glaucoma Research-funded scientist is trying to understand why.
Fact Sheets
Alzheimer’s Disease Facts & Figures
Every three seconds, someone in the world develops dementia. That’s the same amount of time it takes to read this sentence out loud. Get the facts about Alzheimer’s disease—the most common form of dementia.
Macular Degeneration Facts & Figures
Advanced age-related macular degeneration (AMD) is a leading cause of irreversible blindness and visual impairment, affecting nearly 20 million U.S. adults who are living with some form of AMD.
Glaucoma Facts & Figures
More than three million Americans are living with glaucoma, a group of eye disorders that can lead to vision loss or complete blindness.
Press Releases
BrightFocus Foundation Announces President and CEO Planned Retirement and Launches National Search
BrightFocus Foundation today announced that Stacy Pagos Haller has shared her intention to retire as president and chief executive officer following the successful completion of a national search and the appointment of a successor, after 16 years of leadership.
Dr. David Abramson Receives 2026 Helen Keller Prize for Vision Research from BrightFocus Foundation and Helen Keller Foundation
A pioneering clinician-scientist at Memorial Sloan Kettering Cancer Center, Dr. Abramson has transformed understanding and treatment of eye cancers worldwide.
BrightFocus Honors 5 Vision Scientists Advancing Breakthrough Eye Research
At a ceremony recognizing 2026 vision grant recipients, these prestigious awards honor five standout scientists whose work is shaping the future of prevention, treatments, and cures for macular degeneration and glaucoma—two leading causes of vision loss.
Donor Support Powers $16M+ Investment in 69 Projects Tackling Alzheimer’s, Macular Degeneration, and Glaucoma
Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research.
2025 Research Portfolios Spotlight Breakthrough Science
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
New Public Service Campaign Encourages Eye Exams to Save Sight
BrightFocus Foundation’s new national public service announcements raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.
BrightFocus Foundation and Focused Ultrasound Foundation Announce Partnership to Advance Alzheimer’s Research
A three-year collaboration supports pioneering non-invasive treatment strategies for Alzheimer’s disease using focused ultrasound.
BrightFocus and Alzheimer’s Los Angeles Renew Partnership to Fund Promising Alzheimer’s Research
Ongoing collaboration advances promising Alzheimer’s drug discovery research in Southern California.
BrightFocus Foundation Awards Nearly $13M to 50 Scientists for Alzheimer’s, Macular Degeneration, and Glaucoma Research
Private research nonprofit BrightFocus Foundation today announced nearly $13 million in grants to support early investigative research into Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation Announces President and CEO Planned Retirement and Launches National Search
BrightFocus Foundation today announced that Stacy Pagos Haller has shared her intention to retire as president and chief executive officer following the successful completion of a national search and the appointment of a successor, after 16 years of leadership.
Dr. David Abramson Receives 2026 Helen Keller Prize for Vision Research from BrightFocus Foundation and Helen Keller Foundation
A pioneering clinician-scientist at Memorial Sloan Kettering Cancer Center, Dr. Abramson has transformed understanding and treatment of eye cancers worldwide.
BrightFocus Honors 5 Vision Scientists Advancing Breakthrough Eye Research
At a ceremony recognizing 2026 vision grant recipients, these prestigious awards honor five standout scientists whose work is shaping the future of prevention, treatments, and cures for macular degeneration and glaucoma—two leading causes of vision loss.
Donor Support Powers $16M+ Investment in 69 Projects Tackling Alzheimer’s, Macular Degeneration, and Glaucoma
Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research.
2025 Research Portfolios Spotlight Breakthrough Science
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
New Public Service Campaign Encourages Eye Exams to Save Sight
BrightFocus Foundation’s new national public service announcements raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.
BrightFocus Foundation and Focused Ultrasound Foundation Announce Partnership to Advance Alzheimer’s Research
A three-year collaboration supports pioneering non-invasive treatment strategies for Alzheimer’s disease using focused ultrasound.
BrightFocus and Alzheimer’s Los Angeles Renew Partnership to Fund Promising Alzheimer’s Research
Ongoing collaboration advances promising Alzheimer’s drug discovery research in Southern California.
BrightFocus Foundation Awards Nearly $13M to 50 Scientists for Alzheimer’s, Macular Degeneration, and Glaucoma Research
Private research nonprofit BrightFocus Foundation today announced nearly $13 million in grants to support early investigative research into Alzheimer’s disease, macular degeneration, and glaucoma.